Related Experiment Videos
Cytokines, neuropeptides, and other factors in cutaneous immune responses
The Western Journal of Medicine
|February 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Association of calving factors and labor duration with postpartum uterine health in Holstein cattle.
Journal of dairy science·2026
Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma.
Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility.
The British journal of dermatology·2020
Increased tumour cell PD-L1 expression, macrophage and dendritic cell infiltration characterise the tumour microenvironment of ulcerated primary melanomas.
Journal of the European Academy of Dermatology and Venereology : JEADV·2018
An ex vivo RNA trans-splicing strategy to correct human generalized severe epidermolysis bullosa simplex.
The British journal of dermatology·2018
[Mucosal manifestations of epidermolysis bullosa : Clinical presentation and management].
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2016
Analysis of questions asked by family physicians regarding patient care.
The Western journal of medicine·2008
High prevalence of autoantibodies neutralizing type I IFNs in Japanese patients with hepatitis C.
Journal of human immunity·2026
Immunosenescence and immune-organ axis dysfunction: Potential of algal bioactives and nutritional interventions for healthy ageing.
International reviews of immunology·2026
Brief Communication: LSD1 Inhibition Enhances Susceptibility of Primary AML Cells for NK Cell-Mediated Killing.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Somatic Hypermutations Enhance Neutralization Breadth of IGHV3-53/3-66 Public Antibodies Against SARS-CoV-2 Variants.
Immunity, inflammation and disease·2026